ArticleFrontiers in microbiology2020
First Report of New Delhi Metallo-
Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 25 citations in OpenAlex.
- Carbapenem-ResistantMicroorganisms · 2026Article
- Therapeutic challenges and emerging strategies against carbapenem-resistantCurrent research in microbial sciences · 2026Review
- Carbapenem-ResistantMicroorganisms · 2025Review
- Epidemiological characteristics of severe community-acquired pneumonia in children admitted to two tertiary hospitals in Shihezi, Xinjiang Region, China in 2023: a cross-sectional analysis.Journal of thoracic disease · 2024Article
- The Prevalence of Antibiotic Resistance Phenotypes and Genotypes in Multidrug-Resistant Bacterial Isolates from the Academic Hospital of Jaén, Spain.Antibiotics (Basel, Switzerland) · 2024Article
- Genomic Surveillance Uncovers a 10-Year Persistence of an OXA-24/40International journal of molecular sciences · 2024Article
- Healthcare Equipment and Personnel Reservoirs of Carbapenem-ResistantMicroorganisms · 2023Article
- International Clones of High Risk of Acinetobacter Baumannii-Definitions, History, Properties and Perspectives.Microorganisms · 2023Review
- Co-Existence ofInternational journal of molecular sciences · 2023Article
- Article
- Article
- Antimicrobial resistance in Gram-negative bacilli in Spain: an experts' view.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023Article
- Molecular characterization of multidrug resistantFrontiers in cellular and infection microbiology · 2023Article
- Genomic characterization of an NDM-9-producingFrontiers in microbiology · 2023Article
- Plasmid content of carbapenem resistantFrontiers in cellular and infection microbiology · 2023Article
- Molecular Characterization of Carbapenem-ResistantInfection and drug resistance · 2022Review
- Emergence of a Carbapenem-ResistantFrontiers in microbiology · 2022Article
- Wastewaters, with or without Hospital Contribution, Harbour MDR, Carbapenemase-Producing, but Not HypervirulentAntibiotics (Basel, Switzerland) · 2021Article
- Molecular Epidemiology of Carbapenem-ResistantFrontiers in microbiology · 2021Article
- Genomic surveillance ofWestern Pacific surveillance and response journal : WPSARArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of this study was the phenotypic and genotypic characterization of a carbapenem resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.